All In Biotech

Free tool

FAERS Monitor: Retin-A

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 017340 or its brand name (Retin-A, Tretinoin). Reports on generic versions are filed under their own applications.

Reports

7,870

Serious

4,782

61% of reports

Hospitalization

1,663

Death reported

883

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use965
  • drug ineffective813
  • pain586
  • product use in unapproved indication509
  • vomiting504
  • nausea442
  • rash434
  • headache426
  • diarrhoea411
  • paraesthesia397
  • abdominal pain upper387
  • fatigue371
  • hypoaesthesia364
  • drug intolerance346
  • depression344

Reports by year received

View as table
YearReports
200448
200548
200638
200752
2008135
200999
2010112
2011159
2012203
2013118
2014178
2015318
2016528
2017478
2018533
2019455
2020445
2021453
2022576
2023646
2024758
2025887
2026603

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,289 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug intoleranceSignal3469.68.72,661
paraesthesiaSignal3976.86.11,952
hypoaesthesiaSignal3646.55.91,701
product use in unapproved indicationSignal5095.55.11,887
abdominal pain upperSignal3875.04.61,256
depressionSignal3444.03.6793
off label useSignal9652.92.81,292
vomitingSignal5042.92.6624
rashSignal4342.72.4458
painSignal5862.62.4567
headache4261.81.7160
diarrhoea4111.71.5122
drug ineffective8131.61.5221
nausea4421.51.474
fatigue3711.31.222

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.